Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas

Acta Tropica

Volumn 77, Issue 1, 2000, Pages 141-146

  Corrêa Oliveira, Rodrigo ^a   Rodrigues Caldas, Iramaya ^a   Assis Martins Filho, Olindo ^a   Carvalho Queiroz, Claudia ^b   Roberto Lambertucci, José ^b   Renan Cunha Melo, José ^b   Soares Silveira, Alda ^c   Prata, Aluizio ^d   Wilson, Alan ^e   Gazzinelli, Giovanni ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^d FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Endemic areas; Immune response; Schistosoma masoni

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6;

ARTICLE; ENDEMIC DISEASE; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; WATER CONTAMINATION;

ADULT; ANIMAL; ANTIBODIES, HELMINTH; ANTIGENS, CD; BRAZIL; CHILD; ENDEMIC DISEASES; HLA-DR ANTIGENS; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; RECURRENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0342409312     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(00)00127-3     Document Type: Article

References (35)

1. Bina, J.C. (1977). Influência da terapêutica específica na evolução da esquistossomose mansoni. Thesis. Universidade Federal da Bahia.
2. Butterworth A.E., Capron M., Cordingley J.S., Dalton P.R., Dunne D.W., Kariuki H.C. et al. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune response. Trans. R. Soc. Trop. Med. Hyg. 79:1985;393-408.
3. Butterworth A.E., Dalton P.R., Dunne D.W., Mugambi M., Ouma J.H., Richardson B.A. et al. Immunity after treatment of human Schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Trans. R. Soc. Trop. Med. Hyg. 78:1984;108-123.
4. Corrêa-Oliveira R., Malaquias L.C.C., Falcão P.L., Viana I.R.C., Bahia-Oliveira L.M.G., Silveira A.M.S. et al. Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz. J. Med. Biol. Res. 31:1998;171-177.
5. Demeure E.C., Rihet P., Abel L., Ouattara M., Bourgois A., Dessein A.J. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance IgG2 in immunity to reinfection after chemotherapy. J. Infect. Dis. 168:1993;1000-1009.
6. Dessein A.J., Begley M., Demeure C., Caillol D., Fueri J., Reis M.G., Andrade Z., Prata A., Bina J.C. Human resistance to Schistosoma mansoni is associated with IgG reatictivity to a 37-kDa larval surface antigen. J. Immunol. 140:1988;2727-2736.
7. Dunne D.W., Butterworth A.E., Fulford A.J.C., Kariuki H.C., Langley J.G., Ouma J.H., Capron A., Pierce R.J., Strurrock R.F. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1992;1483-1494.
8. Dutra W.O., Martins-Filho O.A., Cançado J.R., Pinto-Dias J.C., Brener Z., Freeman Junior G.L. et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int. Immunol. 6(4):1994;499-506.
9. Falcão P.L., Malaquias L.C., Martins-Filho O.A., Silveira A.M., Passos V.M., Prata A. et al. Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol. 20(10):1998;447-454.
10. Grogan J.L., Kremsner P.G., van Dam G.J., Metzger W., Mordmuller B., Deelder A.M., Yazdanbakhsh M. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J. Infect. Dis. 173:1996;1242-1247.
11. Grzych J.M., Grezel D., XU B.C., Neyrinck J.L., Capron M., Ouma J.H., Butterworth A.E., Capron A. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J. Immunol. 150:1993;527-535.
12. Hagan P., Blumenthal U.J., Dunne D.W., Simpson A.J.G., Wilkins H.A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 6306:1991;243-245.
13. Hofstetter M., Poindexter R.W., Ruiz-Tiben E., Ottesen E.A. Modulation of the host response in human schistosomiasis. III. Blocking antibody specially inhibit immediate hypersensitivity response to parasite antigens. Immunology. 46:1982;777-785.
14. Katz N., Zicker F., Rocha R.S., Oliveira V.B. Re-infection of patients in schistosomiasis mansoni endemic areas after specific treatment. I. influence of age and worm burden. Rev. Inst. Med. Trop. São Paulo. 20:1978;273-278.
15. Katz N., Rocha R.S., Pereira J.P. Controle da equistossomose em Peri-Peri (MG) através de repetidos tratamentos clínicos e aplicações de moluscicida. Ver. Inst. Med. Trop. São Paulo. 14:1980;203-211.
16. Katz, N., 1992. Brazilian contributions to epidemiological aspects of schistosomiasis mansoni. Mem. Inst. Oswaldo Cruz 87, Suppl IV, 1-9.
17. Katz, N., 1998. Schistosomiasis control in Brazil. Mem. Inst. Oswaldo Cruz. 93 (Suppl. 1) 33-35.
18. Kloetzel K. A rationale for the treatment of schistosomiasis mansoni, even when reinfection is expected. Trans. R. Soc. Trop. Med. Hyg. 61:1967;609-610.
19. Malaquias L.C., Falcão P.L., Silveira A.M., Gazzinelli G., Prata A., Coffman R.L., Pizziolo V., Souza C.P., Colley D.G., Corrêa-Oliveira. R. Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand. J. Immunol. 46(4):1997;393-398.
20. Martins-Filho O.A., Mello J.R., Corrêa-Oliveira R. The spleen is an important site of T cell activation during human hepatosplenic schistosomiasis. Mem. Inst. Oswaldo Cruz 93 Suppl. 1:1998;159-164.
21. Martins-Filho O.A., Cunha-Melo J.R., Lambertucci J.R., Silveira A.M., Colley D.G., Gazzinelli G., Corrêa-Oliveira R. Clinical forms of human Schistosoma mansoni infection are associated with differential activation of T-cell subsets and costimulatory molecules. Dig. Dis. Sci. 44(3):1999;570-577.
22. Martins-Filho O.A., Dutra W.O., Freeman G.L., Silveira A.M., Rabello A., Colley D.G. et al. Flow cytometric study of blood leucocytes in clinical forms of human schistosomiasis. Scand. J. Immunol. 46(3):1997;304-311.
23. Medhat A., Shehata M., Bucci K., Mohamed S., Dief A.D.E., Badary S., Galal H., Nafeh M., king C.L. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J. Infect. Dis. 178:1998;512-519.
24. Minóprio P. Chagas' disease: CD5 B-cell-dependent Th2 pathology? Res. Immunol. 142(2):1991;137-140.
25. Ottesen E.A., Kumaraswami A.V., Paranjape R., Poindexter R.W., Tripathy S.P. Naturally occuring blockig antibodies modulate immediate hypersensitivity responses in human filariasis. J. Immunol. 127:1981;2014-2020.
26. Rihet P., Demeure C.E., Bourgois A., Prata A., Dessein A.J. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:1991;2679-2686.
27. Rihet P., Demeure C.E., Dessein A.J., Bourgois A. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from S. mansoni endemic area. Eur. J. Immunol. 22:1992;2063-2070.
28. Silveria A.M.S., Fraga L.A.O., Prata A., Corrêa-Oliveira R., Addiss D.A., Viana I.R.C., Colley D.G., Gazzinelli G. Resistance to infection/ reinfection by Schistosoma mansoni is not augmented by three treatment with 45 days intervals. Men. Inst. Oswaldo Cruz. 93(1):1996;113-114.
29. Velupillai P., Secor W.E., Horauf A.M., Harn D.A. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J. Immunol. 158(1):1997;338-344.
30. Viana I.R.C., Sher A., Carvalho O.S., Massara C.L., Eloi-Santos S.M., Pearce E.J. et al. Interferon-γ production mononuclear cells from residents of an area endemic for Schistosomiasis mansoni. Trans R. Soc. Trop. Med. Hyg. 88:1994;466-470.
31. Viana, I.R.C., Corrêa-Oliveira, R., Carvalho, O.S., Massara, C.L., Colossimo, E., Colley, D.G., Gazzinelli, G., 1995. Comparisons of antibodies isotype responses to Schistosoma mansoni antigens by infected and resistant individuals living in an endemic area. Parasite Immunol. 17, 297-304.
32. Webster M., Fallon P.G., Fuldford A.J.C., Butterworth A.E., Ouma H.J., Kimani G., Dunne D.W. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm. Parasite Immunol. 19:1997;333-335.
33. Wilson R.A., Coulson P.S., Dowling M.A., Betts C., Smythes L.E. Impaired immunity and altered pulmonary response in mice with a disrupted interferon-receptor gene exposed to irradiated Schistosoma mansoni vaccine. Immunology. 87:1996;275-282.
34. Wynn T.A., Oswald J.P., Eltoum I.A., Caspar P., Lowenstein C.J., Lewis F.A., James S.L., Sher A. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:1994;5200-5209.
35. Zhaosong Z., Haiwei W., Suchen C., Lingshen H., Zhangwu X., Yingxi Q. et al. Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. Trans. R. Soc. Trop. Med. Hyg. 91:1997;606-608.